HR Healthcare Realty Trust Inc
- 15.370
- +0.330+2.19%
- 15.080
- -0.290-1.89%
Healthcare Realty Trust Inc News
Healthcare Realty Trust Inc's Dividend Analysis
Healthcare Realty Trust Inc Options Spot-On: On May 9th, 104.86K Contracts Were Traded, With 44,388 Open Interest
On May 9th ET, $Healthcare Realty Trust Inc(HR.US)$ had active options trading, with a total trading volume of 104.86K options for the day, of which put options accounted for 0.01% of the total transa
Healthcare Realty Trust Inc To Go Ex-Dividend On May 10th, 2024 With 0.31 USD Dividend Per Share
May 9th - $Healthcare Realty Trust Inc(HR.US)$ is trading ex-dividend on May 10th, 2024. Shareholders of record on May 13th, 2024 will receive 0.31 USD dividend per share on May 23rd, 2024. The ex
Healthcare Realty Trust Incorporated (NYSE:HR) Q1 2024 Earnings Call Transcript
Cracking The Code: Understanding Analyst Reviews For Healthcare Realty Trust
Healthcare Realty Trust (NYSE:HR) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.The following table encapsulates their recent ratings
Healthcare Realty Trust Price Target Raised to $16.00/Share From $15.00 by Wedbush
Healthcare Realty Trust Price Target Raised to $16.00/Share From $15.00 by Wedbush
Healthcare Realty Trust Is Maintained at Neutral by Wedbush
Healthcare Realty Trust Is Maintained at Neutral by Wedbush
Wedbush: Maintaining the Healthcare Realty Trust (HR.US) rating, adjusted from neutral to neutral, and adjusted the target price from $15.00 to $16.00.
Wedbush: Maintaining the Healthcare Realty Trust (HR.US) rating, adjusted from neutral to neutral, and adjusted the target price from $15.00 to $16.00.
Wedbush Maintains Neutral on Healthcare Realty Trust, Raises Price Target to $16
Wedbush analyst Richard Anderson maintains Healthcare Realty Trust (NYSE:HR) with a Neutral and raises the price target from $15 to $16.
Healthcare Realty Trust Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/08/2024 4.68% Wedbush $15 → $16 Maintains Neutral 04/10/2024 -1.86% Wells Fargo $18 → $15 Maintains Equ
Wedbush Lifts Healthcare Realty Trust's PT to $16 From $15, Keeps Neutral Rating
Healthcare Realty Trust (HR) has an average rating of outperform and price targets ranging from $13 to $20, according to analysts polled by Capital IQ. Price: 15.68, Change: +0.27, Percent Change: +1.
Healthcare Realty Trust Inc (HR) (Q1 2024) Earnings Call Transcript Highlights: Strategic Moves ...
Q1 2024 Healthcare Realty Trust Inc Earnings Call
Earnings Call Summary | Healthcare Realty Trust Inc(HR.US) Q1 2024 Earnings Conference
The following is a summary of the Healthcare Realty Trust, Inc. (HR) Q1 2024 Earnings Call Transcript:Financial Performance:Healthcare Realty Trust reported normalized FFO per share of $0.39 and an ac
Healthcare Realty Trust, Inc. (HR) Q1 2024 Earnings Call Transcript
Healthcare Realty Trust, Inc. (HR) Q1 2024 Earnings Call Transcript
Healthcare Realty Trust Affirms FY2024 FFO Guidance $1.52-1.58 Vs $1.56 Est
Healthcare Realty Trust (NYSE:HR) affirms FY2024 FFO guidance from $1.52-1.58 to $1.52-1.58 vs $1.56 analyst estimate..
Healthcare Realty Trust Q1 Adj. FFO $0.39 Beats $0.38 Estimate, Sales $326.81M Miss $326.89M Estimate
Healthcare Realty Trust (NYSE:HR) reported quarterly FFO of $0.39 per share which beat the analyst consensus estimate of $0.38 by 2.63 percent. This is a 2.5 percent decrease over FFO of $0.40 per sha
Healthcare Realty Trust Q1 Results Beat: Focuses on Capital Allocation
Healthcare Realty Trust's Q1 Normalized FFO, Revenue Fall; Q2, 2024 Normalized FFO Outlook Issued
Healthcare Realty Trust (HR) reported Q1 normalized funds from operations Tuesday of $0.39 per diluted share, down from $0.40 a year earlier. Analysts polled by Capital IQ expected $0.38. Revenue for
Earnings Flash (HR) HEALTHCARE REALTY TRUST INCORPORATED Posts Q1 Revenue $326.8M
07:10 AM EDT, 05/07/2024 (MT Newswires) -- Earnings Flash (HR) HEALTHCARE REALTY TRUST INCORPORATED Posts Q1 Revenue $326.8M
Analysis
Price Target
No Data
